Previous 10 | Next 10 |
2024-01-10 13:00:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2024-01-10 12:15:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2024-01-10 09:30:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2024-01-09 16:26:04 ET Danaher Corporation (DHR) 42nd Annual J.P. Morgan Healthcare Conference January 09, 2024 02:15 PM ET Company Participants Rainer Blair - President and Chief Executive Officer Conference Call Participants Rachel Vatnsdal - JPMorgan ...
Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution PR Newswire New collaborative research center based at University of California, Berkeley ...
2024-01-09 06:19:25 ET More on Danaher Danaher: Continuously Compounding My Top 2024 Stock Pick: Danaher Abcam gains after securing all approvals for Danaher sale, set to close Dec. 6 For further details see: Danaher gives Q4 guidance, expects low double-...
2024-01-08 17:52:55 ET Summary West Pharmaceutical Services has a business model centered around recurring consumption in the pharmaceutical and life sciences industries. The company has experienced consistent growth and has raised its dividend every year for the past 30 years. ...
2024-01-05 18:07:09 ET Summary I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. I share my personal success in beating the market in 2023, with a time-weighted return of 28.02%. I emphasize ...
2024-01-03 10:22:00 ET Summary For dividend-paying stocks, December 2023 was representative of 2023 as a whole. Our sampling of December 2023's unfavorable dividend actions found 14 firms announcing decreases in dividend payments to their shareholding owners. Dividend reductio...
2023-12-28 09:49:30 ET Summary Danaher has undergone a radical transformation from a real estate trust to a leader in the life sciences industry through strategic acquisitions. The company's focus on continuous improvement and efficiency, guided by the Kaizen philosophy, has been ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...